### Value Sets Defined by mCODE

The following value sets are defined in this implementation guide:

* [BenignUncertainNeoplasmBrainCNSDisorderVS]
* [BodyLocationQualifierVS]
* [BrachytherapyPermanentSeedsTechniqueVS]
* [BrachytherapyLowDoseRateTemporaryTechniqueVS]
* [BrachytherapyPulsedDoseRateTechniqueVS]
* [BrachytherapyRadiopharmaceuticalTechniqueVS]
* [BrachytherapyHighDoseRateElectronicTechniqueVS]
* [BrachytherapyHighDoseRateTechniqueVS]
* [BrachytherapyModalityVS]
* [BrachytherapyTechniqueVS]
* [CancerBodyLocationVS]
* [CancerDiseaseStatusEvidenceTypeVS]
* [CancerDisorderVS]
* [CancerRelatedSurgicalProcedureVS]
* [CancerStageGroupVS]
* [CancerStagingSystemVS]
* [CarcinomaInSituDisorderVS]
* [ClinVarVS]
* [ConditionStatusTrendVS]
* [CytologicEvidenceOfMalignancyVS]
* [DNAChangeTypeVS]
* [ElixhauserAIDSVS]
* [ElixhauserAlcoholAbuseVS]
* [ElixhauserBloodLossAnemiaVS]
* [ElixhauserCancerLeukemiaVS]
* [ElixhauserCancerLymphomaVS]
* [ElixhauserCancerMetastaticVS]
* [ElixhauserCancerSolidTumorInSituVS]
* [ElixhauserCancerSolidTumorMalignantVS]
* [ElixhauserCerebrovascularDiseaseVS]
* [ElixhauserChronicPulmonaryDiseaseVS]
* [ElixhauserCoagulationDeficiencyVS]
* [ElixhauserCongestiveHeartFailureVS]
* [ElixhauserDeficiencyAnemiaVS]
* [ElixhauserDementiaVS]
* [ElixhauserDepressionVS]
* [ElixhauserDiabetesComplicatedVS]
* [ElixhauserDiabetesUncomplicatedVS]
* [ElixhauserDrugAbuseVS]
* [ElixhauserHypertensionComplicatedVS]
* [ElixhauserHypertensionUncomplicatedVS]
* [ElixhauserHypothyroidismVS]
* [ElixhauserLiverDiseaseMildVS]
* [ElixhauserLiverDiseaseSevereVS]
* [ElixhauserNeurologicalMovementDisorderVS]
* [ElixhauserNeurologicalSeizureDisorderVS]
* [ElixhauserObesityVS]
* [ElixhauserOtherNeurologicalVS]
* [ElixhauserOtherThyroidDisorderVS]
* [ElixhauserParalysisVS]
* [ElixhauserPeripheralVascularDiseaseVS]
* [ElixhauserPsychosisVS]
* [ElixhauserPulmonaryCirculationDisorderVS]
* [ElixhauserRenalFailureModerateVS]
* [ElixhauserRenalFailureSevereVS]
* [ElixhauserRheumatoidArthritisVS]
* [ElixhauserUlcerVS]
* [ElixhauserValvularDiseaseVS]
* [ElixhauserWeightLossVS]
* [GenomicMolecularConsequenceVS]
* [GenomicSpecimenTypeVS]
* [HGNCVS]
* [HGVSVS]
* [HistologyMorphologyBehaviorVS]
* [HypereosinophilicSyndromeDisorderVS]
* [LateralityQualifierVS]
* [MelanomaInSituDisorderVS]
* [ObservationCodesDistantMetastasesVS]
* [ObservationCodesPrimaryTumorVS]
* [ObservationCodesRegionalNodesVS]
* [ObservationCodesStageGroupVS]
* [PresentAbsentVS]
* [PrimaryCancerDisorderVS]
* [PrimaryMalignantNeoplasmDisorderVS]
* [ProcedureIntentVS]
* [RadiotherapyModalityVS]
* [RadiotherapyTechniqueVS]
* [RadiotherapyTreatmentLocationQualifierVS]
* [RadiotherapyTreatmentLocationVS]
* [RadiotherapyVolumeTypeVS]
* [SecondaryCancerDisorderVS]
* [TeleradiotherapyCarbonIonBeamTechniqueVS]
* [TeleradiotherapyElectronBeamTechniqueVS]
* [TeleradiotherapyModalityVS]
* [TeleradiotherapyNeutronTechniqueVS]
* [TeleradiotherapyPhotonBeamTechniqueVS]
* [TeleradiotherapyProtonBeamTechniqueVS]
* [TeleradiotherapyTechniqueVS]
* [TNMDistantMetastasesCategoryVS]
* [TNMPrimaryTumorCategoryVS]
* [TNMRegionalNodesCategoryVS]
* [TreatmentTerminationReasonVS]
* [TumorMarkerTestVS]
* [TumorSizeMethodVS]
* [TumorSizeUnitsVS]

### External Value Sets Used in mCODE

* [ACMG_Clinical significance of genetic variation]
* [ECOG_Performance status]
* [Genomic coordinate system]
* [Karnofsky performance status]
* [Medication Clinical Drug (RxNorm)]
* [MG_2_Genetic variant source]
* [MG_4_Amino acid change type]
* [MG_5_Genetic variant allelic state]
* [Structural variant analysis method]

{% include markdown-link-references.md %}
